<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-12-02 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-12-02/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-12-02"><meta property="og:description" content="ğŸ“… Daily Report - 2025-12-02 ä»Šæ—¥ç­›é€‰å‡º 152 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-12-02T00:00:00+00:00"><meta property="article:modified_time" content="2025-12-02T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week492025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-12-02"><meta itemprop=description content="ğŸ“… Daily Report - 2025-12-02 ä»Šæ—¥ç­›é€‰å‡º 152 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-12-02T00:00:00+00:00"><meta itemprop=dateModified content="2025-12-02T00:00:00+00:00"><meta itemprop=wordCount content="3177"><meta itemprop=keywords content="Research,Daily,Week492025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-12-02"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-12-02 ä»Šæ—¥ç­›é€‰å‡º 152 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-02</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-12-02T00:00:00Z>2025-12-02</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-12-02>ğŸ“… Daily Report - 2025-12-02</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>152</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
å¯Œé›†CD200+ CD8 Tç»†èƒï¼Œé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’ï¼Œæ˜¾è‘—æå‡æŠ—è‚¿ç˜¤å…ç–«ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢ç²¾æ°¨é…¸å‰¥å¤ºå¯¹å…ç–«ç»†èƒåŠŸèƒ½åŠæŠ—è‚¿ç˜¤ä½œç”¨çš„å½±å“ã€‚</li><li>ç ”å‘æ–°å‹åŒæŠ—åŸDNAç–«è‹—ï¼Œè¯±å¯¼é’ˆå¯¹å…ç–«æŠ‘åˆ¶æ€§å£è…”ç™Œçš„å¼ºæ•ˆæŠ—è‚¿ç˜¤å…ç–«ã€‚</li><li>åˆ©ç”¨å¤šç»„å­¦æ•´åˆæ–¹æ³•ï¼ˆè¡¨è§‚é—ä¼ å­¦ã€ç©ºé—´è½¬å½•ç»„å­¦ï¼‰è§£æè„Šç´¢ç˜¤å¾®ç¯å¢ƒã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç»“åˆscRNA-seqã€ATAC-seqç­‰æŠ€æœ¯ï¼Œå…¨é¢å‰–æå…ç–«ç»†èƒäºšç¾¤åœ¨è‚¿ç˜¤åŠç–¾ç—…å‘ç”Ÿå‘å±•ä¸­çš„ä½œç”¨ã€‚</li><li>åº”ç”¨ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯ï¼Œç²¾ç»†ç»˜åˆ¶ç»„ç»‡å†…å…ç–«ç»†èƒåŠ¨æ€åˆ†å¸ƒä¸åŠŸèƒ½ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç§‘å­¦ç•Œé¦–æ¬¡æ­ç¤ºäº†é˜³å…‰å¦‚ä½•å…³é—­çš®è‚¤å†…æºæ€§ç™Œç—‡é˜²å¾¡æœºåˆ¶ï¼Œå¹¶é˜æ˜äº†æœç³–å¦‚ä½•æ‚„ç„¶åŠ å‰§å…ç–«ç»†èƒçš„ç‚ç—‡ååº”ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>é˜æ˜é˜³å…‰æš´éœ²å¯¼è‡´çš®è‚¤ç»†èƒå†…ç‚ç—‡å¤±æ§åŠç™Œç—‡é£é™©å‡é«˜çš„å…·ä½“åˆ†å­æœºåˆ¶ã€‚</li><li>æ­ç¤ºæœç³–å¦‚ä½•é€šè¿‡å¢åŠ å…ç–«ç»†èƒä¸Šçš„ç‚ç—‡å—ä½“ï¼Œæå‡å…¶å¯¹ç»†èŒæ¯’ç´ çš„æ•æ„Ÿæ€§ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å‘ç°é˜³å…‰æ¿€æ´»çš„â€œå¼€å…³â€è°ƒæ§çš®è‚¤ç™Œé˜²å¾¡ã€‚</li><li>è¯†åˆ«æœç³–è¯±å¯¼çš„å…ç–«ç»†èƒè¶…æ•ååº”ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (150æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE311149 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–«[scRNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311149">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE311148 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–«[RNA-Seq 2]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311148">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE311146 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–«[RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311146">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE311145 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–« [ATAC-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311145">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE310571 åŒæŠ—åŸç‹—éª¨DNAç–«è‹—å¯è¯±å¯¼é’ˆå¯¹å…ç–«æŠ‘åˆ¶æ€§å£è…”ç™Œçš„å¼ºæ•ˆæŠ—è‚¿ç˜¤å…ç–«åŠ›</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immunityã€vaccineã€antigen</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Grace Tan ; Natalia Savelyeva ; Chuan Wang ; Martina Meschis ; Christian OttensmeierSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusImmunotherapy has demonstrated durable responses in a subset of patients with head and neck cancer, offering potential survival benefits to those with poor prognoses and resistance to first-line treatments. Despite this, only a modest 15-20% are shown to respond. Cancer vaccines have recently demonstrated efficacy in some solid tumours including melanoma, as well as immune-cold pancreatic and liver cancer, inducing a cytotoxic T cell response and eradicating cancer cells. Our previous research identified cancer testis antigens MAGED4B and FJX1 as highly immunogenic and overexpressed in the majority of HPV-independent head-and-neck squamous cell carcinoma (HPVnegHNSCC) patients. In this study, we developed a novel DNA vaccine utilising the non-plasmid doggyboneTM (dbDNATM) platform to deliver these antigens for targeting head and neck cancer. A series of doggyboneTM vaccine prototypes targeting MAGED4B and FJX1 were generated both to optimise the backbone and to present antigens in an immunogenic form. Vaccine immunogenicity and cytotoxicity were accessed using interferon-gamma. Enzyme-Linked Immunospot (ELISpot) assay. Vaccine efficacy was evaluated in the MOC-2 oral cancer model through tumour monitoring, assessing the infiltration of CD4+, CD8+ and regulatory T cells by immunohistochemistry as well as RNAseq analysis. The optimised dual antigen dbDNA DNA vaccine significantly reduced tumour size. Furthermore, combining the vaccine with anti-PD1 therapy significantly delayed tumour growth and metastasis, thereby enhancing survival in tumour-bearing mice. Vaccination resulted in significant recruitment of CD4+ and CD8+ T cells but not regulatory T cells. IHC analysis also confirmed the ability of dbDNAâ„¢ vaccine TGL-100 OPT in shifting M2 to M1 polarisation, highlighting their therapeutic promise. Transcriptomic analysis of immune cells in the tumour indicates that vaccination promotes long term anti-tumour responses by upregulating memory T cell genes T cell factor-7 (Tcf7) and lymphoid enhancer binding factor 1 (Lef1) while suppressing PDL-1 and inhibiting anti-inflammatory cytokines such as IL-10 and IL-27. These findings suggest that our cancer vaccine effectively recruits cytotoxic T cells to immune cold tumours, minimising the hostâ€™s immune inhibitory mechanisms within&mldr;</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310571">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE308436 éª¶éª¨è„Šç´¢ç˜¤è¡¨è§‚é—ä¼ å­¦ã€ç©ºé—´è½¬å½•ç»„å­¦å’Œå…ç–«å¾®ç¯å¢ƒçš„å¤šæ¨¡æ€æ•´åˆç ”ç©¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€spatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yee H Foong ; George Jour ; Garima Sinha ; Jamal Benhamida ; Nathan Aleynick ; Yanyun Li ; Travis Hollmann ; Mrinal Gounder ; Rohan Sardana ; Carla Saoud ; Max Vaynrub ; Patrick Boland ; Rami Vanguri ; Meera HameedSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensMultimodal study elucidated the complex epigenetic and immunological landscape in sacral chordomas</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308436">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE310136 ç²¾å‡†çº³ç±³ç–—æ³•é‡å¡‘è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒï¼Œé€†è½¬èƒ°è…ºç™Œä¸­çš„å…ç–«æŠ‘åˆ¶ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€macrophage</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yunching Chen ; Hsin-Mei LeeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive stroma rich in tumor-associated macrophages (TAMs) that limit the therapeutic efficacy. We introduce a TAM-targeted nanotherapy platform that selectively delivers either a CSF1R inhibitor or the STING agonist cGAMP to immunosuppressive TAMs. While CSF1R inhibitorâ€“loaded nanoparticles efficiently depleted TAMs and produced moderate antitumor effects, TAM-targeted cGAMP nanoparticles reprogrammed TAMs into immune-stimulating effectors. This reprogramming normalized aberrant vasculature, alleviated desmoplasia, and enhanced infiltration and activation of cytotoxic immune cells. In combination with gemcitabine, PD-1 checkpoint blockade, or CAR-NK cell therapy, TAM-targeted STING activation provided an in situ immunostimulatory signal that markedly improved antitumor efficacy in preclinical PDAC models. Ex vivo efficacy in human PDAC tissues and a favorable safety profile show the translational potential of this TAM-targeted nanotherapy to overcome the immune desert of PDAC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310136">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE306162 SPP1+å·¨å™¬ç»†èƒä¿ƒè¿›æ¥è§¦æ€§è¿‡æ•å¼•èµ·çš„æ¯›å‘ç”Ÿé•¿[ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kai-Rong Huang ; Sabrina Mai-Yi Fan ; Sung-Jan LinSeries Type : OtherOrganism : Mus musculusUsing Visium HD spatial transcriptomics and immunostaining, we mapped skin compartment dynamics during DPCP-induced allergic contact dermatitis. Dermal white adipose tissue transitioned from metabolic homeostasis to immune activation and inflammatory remodeling, accompanied by sustained lipolysis. Concurrently, CD45âº immune cells accumulated in the lower dermis and dWAT. These findings identify dWAT as an immune-metabolic hub orchestrating inflammatory progression and highlight spatial transcriptomics as a powerful tool for dissecting skin niche regulation.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306162">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE296929 E2F4/SETD1Aè½´ä»‹å¯¼çš„METTL3ç”²åŸºåŒ–é€šè¿‡æŠ‘åˆ¶å†…æºæ€§é€†è½¬å½•å…ƒä»¶è¡¨è¾¾ä¿ƒè¿›è‚¿ç˜¤å…ç–«é€ƒé€¸</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Methylation profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensColorectal cancer (CRC) progression and recurrence persist as major clinical challenges despite standard therapies. Emerging evidence underscores that tumor relapse arises from crosstalk between malignant cells and the immunosuppressive microenvironment, yet the role of non-histone lysine methylation in this interplay remains unclear. Here, we identify di-methylation of lysine 513 (K513) on methyltransferase-like 3 (METTL3) as a key epigenetic modification associated with CRC progression and recurrence. Mechanistically, we reveal that SETD1A catalyzes METTL3 K513 methylation, enhancing its binding affinity to S-adenosylmethionine (SAM) and augmenting RNA mâ¶A deposition. Strikingly, METTL3 methylation suppresses endogenous retroelements expression, leading to impaired type I interferon responses and tumor immune evasion. We further uncover a fluorouracil-induced E2F4/SETD1A/METTL3 regulatory axis, wherein E2F4 self-regulation activates SETD1A to drive METTL3 methylation. Targeting this axis through pharmacological inhibition of E2F4 or genetic disruption of METTL3 methylation synergizes with immune checkpoint blockade (ICB), significantly suppressing tumor growth. Our findings unveil a methylation-dependent regulatory mechanism that reshapes the tumor immune microenvironment, offering a novel therapeutic strategy for CRC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296929">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE276263 Epigenetic insights into fertility: involvement of immune cell methylation in dairy cows reproduction</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€epigeneticã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lotfi Bouzeraa ; Helene Martin ; Clement Plessis ; Pascal Dufour ; Jessica C Marques ; Sydney Moore ; Ronaldo Cerri ; Marc-Andre SirardSeries Type : OtherOrganism : Bos taurusInfertility and post-partum reproductive diseases present significant clinical and economic challenges, particularly in cattle farming. Successful gestation is largely contingent upon the ability of the maternal immune system to recognize and tolerate the embryo. The role of immune cells in promoting fetal-maternal immune tolerance is critical, underlining their importance in post-partum fertility. In this context, DNA methylation in hematopoietic cells may play a pivotal role in determining the susceptibility of the animal to post-partum fertility problems. Identifying epigenetic changes linked to infertility is therefore crucial for advancing sustainable animal production. Characterizing the methylome of immune cells in relation to fertility will enable early phenotyping, setting the stage for innovative methods to detect potential subfertility in animals. In our study, whole epigenome sequencing and enzymatic methyl-seq (EM-seq) were employed to analyze the DNA methylation patterns in total blood collected from twelve Holstein cows raised on the same farm before any disease appeared. This approach helped to map the epigenetic modification profiles of genes associated with the varying fertility phenotypes observed the following year, revealing significant differences between fertile and subfertile cows. We identified 216,990 differentially methylated cytosines (DMCs), with three genes, Interferon tau-3 (IFNT3), KIAA0825, and RAS-Related Protein 2A (RAP2A), showing high significance. Additionally, 23 key genes affected by DMCs across five regions (transcription start sites-TSS shores, introns, exons, distal intergenic areas, and downstream of genes) were identified. Notably, Interferon tau-3 emerged as especially crucial due to its role in early embryonic development and the establishment of gestation in cattle, with seven DMCs in its TSS shores in subfertile cows. Similarly, the KLRA1 gene (Ly49), analogous to KIRs in humans and primarily expressed on Natural Killer (NK) cells, was highlighted for its potential impact on fertility. Past research underscored that a balance between activating and inhibiting KIR receptors is essential for embryo implantation and proper placental development. Moreover, interleukin genes, such as IL-6, IL15, IL22, IL-36G, which are vital f&mldr;</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276263">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 140 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä½ çš„çš®è‚¤æœ¬èº«å…·æœ‰æŠ—ç™Œæœºåˆ¶ï¼Œè€Œé˜³å…‰ä¼šå°†å…¶å…³é—­ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šScientists have uncovered how too much sunlight can flip a hidden switch inside skin cells that makes inflammation spiral out of control and increases the risk of cancer. Their research reveals that UV radiation breaks down a protective protein called YTHDF2, which normally prevents a small RNA signal from activating an immune sensor linked to dangerous inflammation. Once that protection is lost, a surprising chain reaction unfolds inside the cell, turning ordinary sun damage into a potential cancer trigger.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251129044505.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>Fructose may quietly supercharge your inflammation</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers found that fructose can prime immune cells to overreact to bacterial toxins. In healthy adults, fructose-sweetened drinks increased receptors that trigger inflammation. This heightened sensitivity may contribute to greater infection risk. The effects could be even more dangerous in people with metabolic diseases.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251129044507.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>RNA-seq</td><td>26</td></tr><tr><td>cancer</td><td>22</td></tr><tr><td>tumor</td><td>11</td></tr><tr><td>transcriptome</td><td>10</td></tr><tr><td>scRNA</td><td>9</td></tr><tr><td>sequencing</td><td>9</td></tr><tr><td>ChIP-seq</td><td>8</td></tr><tr><td>metabolism</td><td>8</td></tr><tr><td>pathway</td><td>8</td></tr><tr><td>immune</td><td>7</td></tr><tr><td>ATAC-seq</td><td>6</td></tr><tr><td>T cell</td><td>6</td></tr><tr><td>macrophage</td><td>6</td></tr><tr><td>methylation</td><td>6</td></tr><tr><td>cytokine</td><td>6</td></tr><tr><td>metabolic</td><td>6</td></tr><tr><td>glioma</td><td>5</td></tr><tr><td>inflammation</td><td>5</td></tr><tr><td>immunity</td><td>5</td></tr><tr><td>RNAseq</td><td>5</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (140æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270483">GSE270483 Macrophage Involvement in the Pathology of Chronic Thromboembolic Pulmonary Hypertension: Lessons from Single-Cell and Single-Nucleus RNA Sequencing</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268779">GSE268779 æ¯”è¾ƒç©ºé—´è½¬å½•ç»„å›¾è°±ä¸­æ‰°åŠ¨å“åº”åŒºåŸŸå’ŒåŸºå› çš„é‰´å®š</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239497">GSE239497 CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310633">GSE310633 OsVAL2 è¿‡è¡¨è¾¾ææ–™çš„åŸå§‹ ChIP-seq æ•°æ®ï¼Œä½¿ç”¨æŠ— FLAG æŠ—ä½“ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275484">GSE275484 äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„ä¸€ä¸ªåŠŸèƒ½äºšç¾¤ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³ - RNA-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275225">GSE275225 ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³çš„äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„åŠŸèƒ½äºšç¾¤ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275224">GSE275224 ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³çš„äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„åŠŸèƒ½äºšç¾¤ [scATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311807">GSE311807 äººç±»å°èƒ¶è´¨ç»†èƒå¯¹ä½“å†…Î²-æ·€ç²‰æ ·è›‹ç™½ã€tauè›‹ç™½å’Œé˜¿å°”èŒ¨æµ·é»˜ç—…ç—…ç†çš„æ··åˆååº”å­˜åœ¨å·®å¼‚[scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311534">GSE311534 Lamin A/C è°ƒèŠ‚è„‚è´¨ä»£è°¢å’Œç‚ç—‡ï¼šæ¥è‡ªå®¶æ—æ€§éƒ¨åˆ†è„‚è‚ªè¥å…»ä¸è‰¯ 2 äºšå‹ 2 æ¨¡å‹çš„å¯ç¤º</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311533">GSE311533 å±‚ç²˜è›‹ç™½A/Cè°ƒèŠ‚è„‚è´¨ä»£è°¢å’Œç‚ç—‡ï¼šæ¥è‡ªå®¶æ—æ€§éƒ¨åˆ†è„‚è‚ªè¥å…»ä¸è‰¯2äºšå‹æ¨¡å‹çš„å¯ç¤º</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311524">GSE311524 è°·æ°¨é…°èƒºé™åˆ¶æ¡ä»¶ä¸‹è½¬å½•ç»„å’Œè›‹ç™½è´¨ç»„ååº”è§£è€¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311344">GSE311344 B16 è‚¿ç˜¤æ¨¡å‹ä¸­ T ç»†èƒçš„ ACT å’Œæ£€æŸ¥ç‚¹é˜»æ–­ - scRNA-seqã€CITE-seq å’Œ TCRab [i35]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311262">GSE311262 åˆ©ç”¨æ‚£è€…æ¥æºçš„å¼‚ç§ç§»æ¤ç»†èƒåœ¨å·¥ç¨‹åŒ–ç»„ç»‡æ¨¡å‹ä¸­é‡ç°æ‚£è€…é—´ç»“ç›´è‚ ç™Œè‚¿ç˜¤å¼‚è´¨æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308942">GSE308942 ErbB3å—ä½“é…ªæ°¨é…¸æ¿€é…¶è°ƒèŠ‚å°è‚ å±éšœåŠŸèƒ½å’Œç´§å¯†è¿æ¥è›‹ç™½Pmp22çš„è¡¨è¾¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306583">GSE306583 èƒç›˜åˆ«å­•çƒ¯é†‡é…®ä¸è¶³åå°é¼ ä½“æ„Ÿçš®å±‚ã€æµ·é©¬å’Œå°è„‘è½¬å½•ç»„çš„å‘è‚²è½¨è¿¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303697">GSE303697 å•æ ¸ RNA æµ‹åºæ­ç¤ºäº†å…·æœ‰ä¸åŒå…ç–«èƒŒæ™¯çš„å°é¼ ä¾§éš”åŒºç»†èƒå¼‚è´¨æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301537">GSE301537 ç‹¬ç‰¹çš„åºåˆ—ç‰¹å¾å®šä¹‰äº†ç‚ç—‡è®°å¿†çš„è¡¨è§‚é—ä¼ æŒä¹…æ€§ [scATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300583">GSE300583 MOIRA æ˜¯æœè‡æ—¶é’Ÿè›‹ç™½å’ŒåŸºå› èšé›†ä»¥åŠæ­£å¸¸æ˜¼å¤œèŠ‚å¾‹æ‰€å¿…éœ€çš„ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300582">GSE300582 MOIRA æ˜¯æœè‡æ—¶é’Ÿè›‹ç™½å’ŒåŸºå› èšé›†ä»¥åŠæ­£å¸¸æ˜¼å¤œèŠ‚å¾‹æ‰€å¿…éœ€çš„ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289835">GSE289835 ApoE-/- å’Œ Epn1&amp;2-SMCiDKO/ApoE-/- å°é¼  (n=3) ä¸»åŠ¨è„‰çš„å•ç»†èƒ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287445">GSE287445 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [RSK1_KO_RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287444">GSE287444 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [å•æ ¸ç»†èƒæ ¸ç³–ä½“æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287443">GSE287443 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [CRISPR_screen]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287442">GSE287442 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [BMDM_RiboTag-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287441">GSE287441 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [BMDM_Ribo-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287440">GSE287440 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [BCAP_KO_BMDM_Ribo-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285986">GSE285986 å¼‚æŸ“è‰²è´¨ä¿çœŸåº¦æ˜¯æ·‹å·´ç˜¤å’Œå…¶ä»–äººç±»ç™Œç—‡çš„æ²»ç–—å¼±ç‚¹ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285592">GSE285592 å¼‚æŸ“è‰²è´¨ä¿çœŸåº¦æ˜¯æ·‹å·´ç˜¤å’Œå…¶ä»–äººç±»ç™Œç—‡çš„æ²»ç–—å¼±ç‚¹[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285575">GSE285575 Syntaxin-6ä»‹å¯¼çš„è‡ªå™¬èµ‹äºˆè‚ç»†èƒç™Œä¹ä¼æ›¿å°¼è€è¯æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283882">GSE283882 å•ç»†èƒæµ‹åºæ­ç¤ºå¸çƒŸç›¸å…³æ€§ç‰™å‘¨ç‚ä¸­ä¸Šçš®ç»†èƒä¸ CXCR6+ Treg ç»†èƒçš„ç›¸äº’ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282552">GSE282552 é•¿è¯»é•¿ RNA æµ‹åºæ­ç¤ºç²¾ç¥åˆ†è£‚ç—‡ä¸­å…·æœ‰å·®å¼‚å¼‚æ„ä½“ä½¿ç”¨çš„çªè§¦åŸºå›  [çŸ­è¯»é•¿ RNA æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282551">GSE282551 é•¿è¯»é•¿ RNA æµ‹åºæ­ç¤ºç²¾ç¥åˆ†è£‚ç—‡ä¸­å…·æœ‰å·®å¼‚å¼‚æ„ä½“ä½¿ç”¨çš„çªè§¦åŸºå›  [é•¿è¯»é•¿ RNA æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282171">GSE282171 æŠ‘éƒå’Œç„¦è™‘è¯±å¯¼çš„ä»£è°¢é‡ç¼–ç¨‹é€šè¿‡ CBX5 ä¹³é…¸åŒ–ä¿ƒè¿›è‚ç»†èƒç™Œè¿›å±•ï¼šç‰›ç£ºèƒ†é…¸å’Œ PHGDH ä»‹å¯¼çš„é“æ­»äº¡çš„å‚ä¸</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281469">GSE281469 IKAROSã€HDAC1 å’Œ EZH2 å¯¹ç™½è¡€ç—…ä¸­å¼‚æŸ“è‰²è´¨å½¢æˆå’Œè‚¿ç˜¤æŠ‘åˆ¶çš„è°ƒæ§ [Molt4_CT]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281468">GSE281468 Regulation of heterochromatin formation and tumor suppression in leukemia by IKAROS, HDAC1 and EZH2 [Molt4_RNA]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281327">GSE281327 è‡ªé—­ç—‡è°±ç³»éšœç¢ä¸­çš„æ–°ç”Ÿç»“æ„å˜å¼‚ç ´åç¥ç»å…ƒåŸºå› çš„è¿œç«¯è°ƒæ§ç›¸äº’ä½œç”¨ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281283">GSE281283 è‡ªé—­ç—‡è°±ç³»éšœç¢ä¸­çš„æ–°ç”Ÿç»“æ„å˜å¼‚ç ´åç¥ç»å…ƒåŸºå› çš„è¿œç«¯è°ƒæ§ç›¸äº’ä½œç”¨ [Hi-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277238">GSE277238 ICAM1 mRNAé€šè¿‡dsRNA-ILF2/ILF3é€šè·¯æŠ‘åˆ¶è‚ºç™Œä¸­çš„ç¿»è¯‘ï¼Œå…¶åŠŸèƒ½ç‹¬ç«‹äºè›‹ç™½è´¨ç¼–ç ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277143">GSE277143 ç»†èƒå‘¨æœŸé˜»æ»é€šè¿‡å¢å¼ºè‘¡è„ç³–ä»£è°¢å’ŒIL-2ä¿¡å·ä¼ å¯¼æ¥å¢å¼ºCD8+ Tç»†èƒæ•ˆåº”åŠŸèƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275934">GSE275934 H4K16é…°åŒ–ä¿®é¥°åœ¨ä»£è°¢æ‰°åŠ¨æœŸé—´å¾®è°ƒè½¬å½•ååº”ï¼ˆRNA-seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275933">GSE275933 H4K16é…°åŒ–ä¿®é¥°åœ¨ä»£è°¢æ‰°åŠ¨æœŸé—´å¾®è°ƒè½¬å½•ååº”ï¼ˆChIP-seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275932">GSE275932 H4K16é…°åŒ–åœ¨ä»£è°¢æ‰°åŠ¨æœŸé—´å¾®è°ƒè½¬å½•ååº”ï¼ˆATAC-seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274750">GSE274750 PMEPA1çš„è‡´ç™Œä½œç”¨åŠå…¶ä¸è‚ç»†èƒç™Œä¸­å…ç–«è€—ç«­å’ŒTGF-Î²æ¿€æ´»çš„å…³ç³»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271675">GSE271675 å‰åˆ—è…ºç™Œä»åŸå‘åˆ°è½¬ç§»æ‰©æ•£çš„è‚¿ç˜¤å¼‚è´¨æ€§åŠ¨æ€å˜åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271622">GSE271622 è‚ ç¥ç»å…ƒä¸¢å¤±å¯¹è‚ é“ç»†èƒç»„æˆçš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268561">GSE268561 ç ”ç©¶å‘ç°ï¼Œå‘è‚²æœŸæš´éœ²äºç”²é…¯ç£ºé…¸ç›å¯é€šè¿‡æ‰°ä¹± Notch/Hes ä¿¡å·é€šè·¯ï¼Œç ´åç¥ç»å…ƒåˆ†åŒ–ï¼Œä»è€Œè¯±å¯¼å°é¼ å‡ºç°ç±»ä¼¼è‡ªé—­ç—‡çš„è¡Œä¸ºç¼ºé™·ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266425">GSE266425 ç£·é…¸åŒ– RB æŠ‘åˆ¶ ETS1 çš„è½¬å½•æ´»æ€§ï¼Œä»è€Œè°ƒèŠ‚å‰åˆ—è…ºç™Œç»†èƒå¯¹ CDK4/6 æŠ‘åˆ¶å‰‚çš„æ•æ„Ÿæ€§ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259251">GSE259251 ndufs2-/-æ–‘é©¬é±¼æ¨¡å‹è¡¨ç°å‡ºè±æ°ç»¼åˆå¾çš„ç‰¹å¾ï¼ŒåŒ…æ‹¬å¯¿å‘½ç¼©çŸ­ã€å‘è‚²å¼‚å¸¸ã€è½¬å½•ç»„æ”¹å˜å’Œä»£è°¢ç´Šä¹±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249943">GSE249943 ä¹³è…ºç™Œç»†èƒèƒ½å¤Ÿè¯†åˆ«å¹¶å“åº”ä¸åŒæ°´å¹³çš„å­•æ¿€ç´ ï¼Œä»è€Œäº§ç”Ÿä¸åŒçš„è¡¨å‹è¾“å‡º [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249939">GSE249939 ä¹³è…ºç™Œç»†èƒèƒ½å¤Ÿè¯†åˆ«å¹¶å“åº”ä¸åŒæ°´å¹³çš„å­•æ¿€ç´ ï¼Œä»è€Œäº§ç”Ÿä¸åŒçš„è¡¨å‹è¾“å‡º [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239353">GSE239353 CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE223746">GSE223746 Single-cell Transcriptome Atlas of the uroclepsia Rat urethra with LIPUS treatment</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185914">GSE185914 Integrating multi-omics data with genome scale metabolic modeling for the analysis of Pseudomonas aeruginosa persister cells</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138321">GSE138321 Microbial activation of intestinal TLRs is critical for the establishment of normal behavior</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271330">GSE271330 CBLL1 (HAKAI) RNAç”²åŸºè½¬ç§»é…¶å¤åˆç‰©ç»„åˆ†åœ¨ä¹³è…ºç™Œç»†èƒï¼ˆMDA-MB-231ï¼‰é›„æ¿€ç´ ä¿¡å·ä¼ å¯¼ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271326">GSE271326 CBLL1 (HAKAI) RNAç”²åŸºè½¬ç§»é…¶å¤åˆç‰©æˆåˆ†åœ¨ä¹³è…ºç™Œç»†èƒ (MCF-7) åŸºç¡€ä¿¡å·ä¼ å¯¼å’Œé›Œæ¿€ç´ ä¿¡å·ä¼ å¯¼ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234571">GSE234571 METTL3:METTL14 RNAç”²åŸºè½¬ç§»é…¶è°ƒæ§MDA-MB-231ä¹³è…ºç™Œç»†èƒä¸­çš„åŸºå› è¡¨è¾¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234322">GSE234322 METTL3 RNAç”²åŸºè½¬ç§»é…¶æŠ‘åˆ¶å¯¹ä¹³è…ºç™Œç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195532">GSE195532 METTL3 RNAç”²åŸºè½¬ç§»é…¶è°ƒæ§MCF-7ä¹³è…ºç™Œç»†èƒä¸­çš„é›Œæ¿€ç´ ä¿¡å·ä¼ å¯¼</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195487">GSE195487 RNAç”²åŸºè½¬ç§»é…¶å¤åˆç‰©çš„METTL14ç»„åˆ†å½±å“MCF-7ä¹³è…ºç™Œç»†èƒä¸­çš„é›Œæ¿€ç´ ä¿¡å·ä¼ å¯¼</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284223">GSE284223 è¡¨çš®ç‰¹å¼‚æ€§ Nampt cKO å°é¼ çš®è‚¤çš„ç»¼åˆè½¬å½•ç»„åˆ†æã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310631">GSE310631 æ°´ç¨»åŸºå›  OsVAL2 è¿‡è¡¨è¾¾å’Œæ•²é™¤çªå˜æ ªç³»çš„åŸå§‹ RNA-seq æ•°æ®ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310630">GSE310630 æ°´ç¨»åŸºå›  OsDOF3 çš„é‡ç”Ÿå‹å’Œè¿‡è¡¨è¾¾æ ªç³»çš„åŸå§‹ RNA-seq æ•°æ®ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272216">GSE272216 äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„ä¸€ä¸ªåŠŸèƒ½äºšç¾¤ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311743">GSE311743 Modeling Liver Cancer Molecular and Histological Features by CRISPR Editing of Primary Porcine Hepatocytes</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311543">GSE311543 Trithorax é€šè¿‡ Ptx1 ä»‹å¯¼çš„ EE ç‰¹åŒ–æŠ‘åˆ¶æ¥å¹³è¡¡ ISC å‘½è¿å†³å®š [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311542">GSE311542 Trithorax é€šè¿‡ Ptx1 ä»‹å¯¼çš„ EE ç‰¹åŒ–æŠ‘åˆ¶æ¥å¹³è¡¡ ISC å‘½è¿å†³å®š [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311496">GSE311496 ç ”ç©¶å¹²ç‡¥ç»¼åˆå¾å’Œéå¹²ç‡¥ç»¼åˆå¾ç›¸å…³å¹²çœ¼ç—‡çš„ç»“è†œå…ç–«é€šè·¯</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311255">GSE311255 ç”¨äºç”Ÿç‰©ç›‘æµ‹å’Œæœºåˆ¶ç ”ç©¶çš„RNAç±»åˆ«å¤æ‚è½¬å½•ç»„å­¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311144">GSE311144 é€šè¿‡åŒParABSåˆ†åŒºç³»ç»Ÿç¨³å®šé—ä¼ é“¾éœ‰èŒçº¿æ€§è´¨ç²’SCP1 [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311079">GSE311079ï¼šç”¨CM-PEG-PLGA@DOX/R848çº³ç±³é¢—ç²’å¤„ç†RAW264.7ç»†èƒä¸PBSå¯¹ç…§ç»„çš„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311078">GSE311078ï¼šCM-PEG-PLGA@DOX/R848çº³ç±³é¢—ç²’å¤„ç†4T1ç»†èƒä¸PBSå¯¹ç…§ç»„çš„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311038">GSE311038 å¤åˆ¶æ€§è¡°è€æ¨¡å‹ä¸­è¡°è€å†…çš®ç»†èƒåŠå…¶è¡ç”Ÿç»†èƒå¤–å›Šæ³¡çš„å¤šç»„å­¦æ•´åˆæ–¹æ³• [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310979">GSE310979 å¶é…¸ç»“åˆè›‹ç™½è¯±å¯¼KBç™Œç»†èƒæ¯’æ€§çš„ä¿¡å·ä¼ å¯¼å’Œæœºåˆ¶ç ”ç©¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310845">GSE310845 è‚ é“å¹²ç»†èƒå’Œç¥–ç»†èƒåœ¨ç‚ç—‡æ€§è‚ ç—…ä¸­å¯¹ç‚ç—‡åº”æ¿€è¡¨ç°å‡ºä¸åŒçš„é€‚åº”æ€§ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310735">GSE310735 YBX1 è°ƒèŠ‚ç»†èƒç¨³æ€ä»¥é¢„é˜²ç‚ç—‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310703">GSE310703 äººç±»æˆçº¤ç»´ç»†èƒ MRC5 ç»†èƒåœ¨ RAF ç™ŒåŸºå› æ¿€æ´»åçš„åŸºå› è¡¨è¾¾è°±åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310275">GSE310275 è½¬å½•å› å­ OsWRKY36 é€šè¿‡è°ƒèŠ‚æ²¹èœç´ ç”¾é†‡ä¿¡å·ä¼ å¯¼æ¥è°ƒæ§æ°´ç¨»å¶ç‰‡å…³èŠ‚å‘è‚²å’Œå¶ç‰‡è§’åº¦ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310085">GSE310085 èåœç¡«ç´ é€šè¿‡æŠ‘åˆ¶PI3K/AKT/mTORå’ŒHIF-1Î±é€šè·¯æŠ‘åˆ¶ç»“ç›´è‚ ç™Œè¿›å±•ï¼Œä¸”åœ¨ç¼ºæ°§æ¡ä»¶ä¸‹ç–—æ•ˆå¢å¼º</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307273">GSE307273 å¹´é¾„ç›¸å…³çš„ G-å››é“¾ä½“ç§¯ç´¯å’Œ DDX5 ä¸¢å¤±å¡‘é€ äººç±»æ˜Ÿå½¢èƒ¶è´¨ç»†èƒçš„æŸ“è‰²è´¨æ™¯è§‚ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307272">GSE307272 å¹´é¾„ç›¸å…³çš„ G-å››é“¾ä½“ç§¯ç´¯å’Œ DDX5 ä¸¢å¤±å¡‘é€ äººç±»æ˜Ÿå½¢èƒ¶è´¨ç»†èƒçš„æŸ“è‰²è´¨æ™¯è§‚ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306951">GSE306951 åˆ©ç”¨èœ‚èƒ¶æå–ç‰©å¯¹ç»¿è‰²åˆæˆæ°§åŒ–é”Œçº³ç±³é¢—ç²’è¯±å¯¼æ–‘é©¬é±¼å…ç–«ååº”è¿›è¡Œè½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306591">GSE306591 æŸ“è‰²è´¨ç»“åˆçš„ Mtf2 é™åˆ¶åŸå§‹å¤šèƒ½æ€§ä¸­çš„èƒšå¤–å‘è‚²èƒ½åŠ› [scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306510">GSE306510 SPP1+å·¨å™¬ç»†èƒä¿ƒè¿›æ¥è§¦æ€§è¿‡æ•ä¸­çš„æ¯›å‘ç”Ÿé•¿[scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306509">GSE306509 SPP1+å·¨å™¬ç»†èƒä¿ƒè¿›æ¥è§¦æ€§è¶…æ•ååº”ä¸­çš„æ¯›å‘ç”Ÿé•¿[æ‰¹é‡RNAæµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305449">GSE305449 å°é¼ èƒ°è…ºÎ±è°±ç³»ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303631">GSE303631 CDCP1 å’Œå¿ƒè‚Œçº¤ç»´åŒ–åœ¨æ‰©å¼ å‹å¿ƒè‚Œç—… (DCM) å°é¼ æ¨¡å‹ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302326">GSE302326 å®¿ä¸»-ç—…åŸä½“ç›¸äº’ä½œç”¨æœŸé—´çš„ç»„è›‹ç™½ä¹³é…¸åŒ–ï¼šé“œç»¿å‡å•èƒèŒç¾¤ä½“æ„Ÿåº”ä¿¡å·ä¸å®¿ä¸»ä¹³é…¸ä¹‹é—´çš„å¯†åˆ‡å’ŒæŒç»­å…³ç³» [CUT&amp;RUN]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302311">GSE302311 å®¿ä¸»-ç—…åŸä½“ç›¸äº’ä½œç”¨è¿‡ç¨‹ä¸­çš„ç»„è›‹ç™½ä¹³é…¸åŒ–ï¼šé“œç»¿å‡å•èƒèŒç¾¤ä½“æ„Ÿåº”ä¿¡å·ä¸å®¿ä¸»ä¹³é…¸ä¹‹é—´å¯†åˆ‡è€ŒæŒä¹…çš„å…³ç³»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301850">GSE301850 è¡¨çš®ç»†èƒèåˆä¿ƒè¿›ç§€ä¸½éšæ†çº¿è™«ä»èƒšèƒè½¬å½•ç»„å‘å¹¼è™«è½¬å½•ç»„çš„è½¬å˜</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300516">GSE300516 è„‘ç¼ºè¡€å°é¼ æ¨¡å‹ä¸­5-ç”²åŸºèƒå˜§å•¶ä¿®é¥°å’Œè¡¨è¾¾è°±çš„è½¬å½•ç»„èŒƒå›´åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300050">GSE300050 ç‹¬ç‰¹çš„åºåˆ—ç‰¹å¾å®šä¹‰äº†ç‚ç—‡è®°å¿†çš„è¡¨è§‚é—ä¼ æŒä¹…æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299343">GSE299343 æ‰¹é‡ RNA æµ‹åº S64F MAFA é›„æ€§èƒ°å²›</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295793">GSE295793 ç ”ç©¶æ›¿ä»£ç”œå‘³å‰‚å¯¹ä¹³é…¸æ†èŒç”Ÿé•¿å’Œä»£è°¢çš„å½±å“åŠå…¶å¯¹é£Ÿæºæ€§ç—…åŸä½“çš„æ€èŒæœºåˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294870">GSE294870 Tauè›‹ç™½é€šè¿‡å¢å¼ºè„‚è‚ªé…¸Î²-æ°§åŒ–è¯±å¯¼çš„ç»†èƒè¡°è€æ¥æŠ‘åˆ¶èƒ¶è´¨ç˜¤è¿›å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289914">GSE289914 ä¸€ç§æ–°å‹é£Ÿå“å¯æ¢å¤è¥¿æ–¹é¥®é£Ÿè¯±å¯¼çš„MASLDå°é¼ çš„å¼‚å¸¸DNAç”²åŸºåŒ–æ¨¡å¼</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289250">GSE289250 èŠè¯é…šé€šè¿‡æŠ‘åˆ¶è§’è´¨å½¢æˆç»†èƒçš„ TRPV3/NF-ÎºB/CCL3 è½´ç¼“è§£ç‰¹åº”æ€§çš®ç‚çš„çš®è‚¤ç‚ç—‡å’Œç˜™ç—’</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287309">GSE287309 å°é¼ å°‘çªèƒ¶è´¨ç»†èƒSerpina3nç¼ºå¤±å¯¹è„‘è¡°è€çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286298">GSE286298 å¼‚æŸ“è‰²è´¨ä¿çœŸåº¦æ˜¯æ·‹å·´ç˜¤å’Œå…¶ä»–äººç±»ç™Œç—‡çš„æ²»ç–—å¼±ç‚¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285894">GSE285894 æ–°ç”ŸRNA m6Aä¿®é¥°å‚ä¸CRPC-V16Aç¼ºæ°§æ¡ä»¶ä¸‹Tç»†èƒæ´»åŒ–åŸºå› ç‰¹å¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285442">GSE285442 HUä¹™é…°åŒ–é€šè¿‡HDAHä»‹å¯¼å¯¹å¤§è‚ æ†èŒä»£è°¢è¿›è¡Œæ­£åé¦ˆè°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285168">GSE285168 TBX5 å‰‚é‡é™ä½é€šè¿‡ç ´åå¿ƒæˆ¿å¿ƒè‚Œç»†èƒèº«ä»½çš„å‘è‚²åŸºå› è°ƒæ§å¯¼è‡´äººç±»å¿ƒæˆ¿ç–¾ç—… [scATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284720">GSE284720 RNA-seq åˆ†ææ­ç¤ºäº†ç»†é¢—ç²’ç‰© (PM2.5) ä¸­ä¸åŒæœ‰æœºæˆåˆ†å¯¹äººç±»é¼»æˆçº¤ç»´ç»†èƒçš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284078">GSE284078 RNA-Seq åˆ†æäº†ç”¨ SGLT2 æŠ‘åˆ¶å‰‚è¾¾æ ¼åˆ—å‡€æ²»ç–—çš„ Akita å°é¼ å’Œé‡ç”Ÿå‹å¯¹ç…§å°é¼ çš„èƒ°å²›ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279446">GSE279446 å•ä¸ª microRNA é¶æ ‡çš„å»æŠ‘åˆ¶å¯¼è‡´å°é¼ é›Œæ€§ä¸å­• [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276336">GSE276336 ZEB1ä»‹å¯¼çš„ç»“ç›´è‚ ç™ŒHT-29ç»†èƒç³»ä¸Šçš®é—´è´¨è½¬åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274447">GSE274447 å°é¼ è„‘å†…ä½“å†…ç©ºé—´æ‰°åŠ¨åºåˆ—</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274244">GSE274244 Arx åœ¨å‘è‚²ä¸­çš„ä¸­é—´ç¥ç»å…ƒä¸­çš„ä½œç”¨ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274243">GSE274243 Arx åœ¨å‘è‚²ä¸­çš„ä¸­é—´ç¥ç»å…ƒä¸­çš„ä½œç”¨ [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273445">GSE273445 æ¯’è•ˆç¢±æ¿€åŠ¨å‰‚é€šè¿‡é’™-ATPä»£è°¢è½´æ¢å¤é€€åŒ–çš„å”¾æ¶²è…º[snRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272876">GSE272876 åˆ©ç”¨çº³ç±³å­” tRNA æµ‹åºå¯¹ 43 ç§ä¸åŒçš„ RNA ä¿®é¥°è¿›è¡Œæ¯”è¾ƒåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272422">GSE272422 Sirt5 é€šè¿‡è›‹ç™½è´¨èµ–æ°¨é…¸ä¸™äºŒé…°åŒ–è°ƒæ§è½¯éª¨ç»†èƒä»£è°¢å’Œéª¨å…³èŠ‚ç‚å‘å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271303">GSE271303 å¡æ³¢è¥¿æ–¯è‚‰ç˜¤é˜Ÿåˆ—çš„æ•´åˆåŠŸèƒ½åŸºå› ç»„å­¦åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266938">GSE266938 æˆå¹´è‚è„è‚ç»†èƒä¸­ SWI/SNF ATPase æ´»æ€§çš„ç¼ºå¤±ä¼šç ´åæ˜¼å¤œèŠ‚å¾‹åŸºå› è¡¨è¾¾å’Œè‚è„ä¸­æ¢åŠŸèƒ½ [RNAseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266426">GSE266426 ç£·é…¸åŒ– RB æŠ‘åˆ¶ ETS1 çš„è½¬å½•æ´»æ€§ï¼Œä»è€Œè°ƒèŠ‚å‰åˆ—è…ºç™Œç»†èƒå¯¹ CDK4/6 æŠ‘åˆ¶å‰‚çš„æ•æ„Ÿæ€§ [CUT&amp;Tag]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261053">GSE261053 RNAPII ç»•è¿‡é˜»æ–­æŸä¼¤æ­ç¤º DNA æŸä¼¤æŠµæŠ—çš„å…³é”®è§è§£ [PRO-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260852">GSE260852 é»è¿è›‹ç™½åè°ƒ RNA èšåˆé…¶ II è½¬å½•çš„å¤šæ­¥éª¤è¿‡ç¨‹ [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252312">GSE252312 åŸºäºåŒ–å­¦åˆ†å­ç­›é€‰çš„å¤©ç„¶äººç±»èƒšèƒå¹²ç»†èƒæ–°å‹åŸ¹å…»ç³»ç»Ÿ[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252086">GSE252086 å¿ƒè‚Œæ¢—æ­»åå•æ ¸ç»†èƒå‘½è¿å†³å®šçš„é—ä¼ å®šä½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250411">GSE250411 å¼‚äº®æ°¨é…°-tRNAåˆæˆé…¶1æ–°çªå˜é€šè¿‡ç¨³å®šç»„ç»‡è›‹ç™½é…¶Zä¿ƒè¿›è‚ºè¡¨é¢æ´»æ€§ç‰©è´¨çš„æ²‰ç§¯[scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250270">GSE250270 å¼‚äº®æ°¨é…°-tRNA åˆæˆé…¶ 1 çš„æ–°çªå˜é€šè¿‡ç¨³å®šç»„ç»‡è›‹ç™½é…¶ Z ä¿ƒè¿›è‚ºè¡¨é¢æ´»æ€§ç‰©è´¨çš„æ²‰ç§¯ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250140">GSE250140 è‚ºç»†èƒç‰¹å¼‚æ€§é©±åŠ¨å› å­å¯¹ç¿»è¯‘æ ¸ç³–ä½“äº²å’Œçº¯åŒ–-RNAæµ‹åº (TRAPseq) çš„æ¯”è¾ƒç ”ç©¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249945">GSE249945 ä¹³è…ºç™Œç»†èƒèƒ½å¤Ÿè¯†åˆ«å¹¶å“åº”ä¸åŒæ°´å¹³çš„å­•æ¿€ç´ ï¼Œä»è€Œäº§ç”Ÿä¸åŒçš„è¡¨å‹ç»“æœ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247828">GSE247828 Bulk RNA-seq analysis of nilotinib resistant JURL-MK1 cells compared against parental JURL-MK1 cells.</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247827">GSE247827 Single cell RNA-seq analysis of the effects of fluphenazine and/or nilotinib on primary CML CD34+CD38- cells</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247826">GSE247826 Bulk RNA-seq analysis for knockdowns of dopamine receptors DRD3 or DRD4 in JURL-MK1 cells +/- TKI (nilotinib) in vitro.</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242511">GSE242511 Reciprocal inflammatory signals establish profibrotic cross-feeding metabolism [young_old_bleo]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237235">GSE237235 Integrative genome-wide analysis reveals the RNA-binding motifs of yeast Pcf11 and its role in fine-tuning terminator strength</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224011">GSE224011 Fc glyco-engineered PD-L1 antibody harnesses Fcg Receptors for increased antitumor efficacy</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221069">GSE221069 Effects of gestational exposure to air pollution on placental methylation mark</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE220648">GSE220648 Nascent RNA-seq from in-vitro stimulated WT and Il2ra-deficient CD8 T cells</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE207991">GSE207991 High-throughput single cell RNA-sequencing of developing lens for cataract gene discovery</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE203198">GSE203198 Integrated control of mitochondrial dynamics and cancer cell stemness by Ïƒ1 receptor</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196382">GSE196382 Defining transcripts regulated by RBBP4/p300 complex in glioblastoma [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196381">GSE196381 Mapping chromatin landscape regulated by RBBP4/p300 complex in glioblastoma [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189447">GSE189447 RNA sequencing of glk1 glk2 double mutants under LD conditions at ZT16</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE175810">GSE175810 An ancestral inductive program endows neural crest cells with skeletogenic potential [scATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE168398">GSE168398 De novo methylation enforces long-term lineage-specific programing of TFH and TH1 memory cells [WGBS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160065">GSE160065 A facile dCAS9-M. EcoGII system for targeted DNA 6mA methylation in living cell</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108449">GSE108449 Altas of gene expression in mice liver during liver regeneration process post 2/3 partial hepatectomy using RNA-seq</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-01 21:32</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week492025/ rel=tag>Week492025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-12-01/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-01</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-12-03/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-03</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-12-24/>ç§‘ç ”æ—¥æŠ¥ 2025-12-24</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-12-23/>ç§‘ç ”æ—¥æŠ¥ 2025-12-23</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-12-22/>ç§‘ç ”æ—¥æŠ¥ 2025-12-22</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-12-21/>ç§‘ç ”æ—¥æŠ¥ 2025-12-21</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-12-20/>ç§‘ç ”æ—¥æŠ¥ 2025-12-20</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (56)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (56)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2025 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>